Biogen Inc.
- Stock
- Ticker BIIB
- ISIN US09062X1037
- Nasdaq
Performance, volatility and drawdowns of Biogen Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $7,841. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −72.7% in 04/2025, measured from the peak in 06/2021. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 2,455 | 2,431 | 2,646 | 2,535 | 2,279 | 2,478 | 2,736 | 2,804 |
| Gross profit | 1,871 | 1,802 | 2,041 | 1,860 | 1,784 | 1,817 | 1,959 | 2,056 |
| Net income | 267 | 241 | 635 | 467 | -49 | 320 | 98 | -21 |
| Earnings per share | 1.83 | 1.64 | 4.33 | 3.17 | -0.35 | 2.15 | 0.66 | -0.14 |
| Balance sheet | ||||||||
| Total assets | 28,049 | 28,033 | 28,330 | 29,208 | 29,440 | 29,483 | 32,087 | 32,054 |
| Liabilities | 11,333 | 11,054 | 10,696 | 11,000 | 11,183 | 10,831 | 13,239 | 13,132 |
| Equity | 16,716 | 16,979 | 17,634 | 18,208 | 18,257 | 18,652 | 18,848 | 18,922 |
| Cash | 2,375 | 2,598 | 2,759 | 3,863 | 3,009 | 3,383 | 1,285 | 1,304 |
| Long-term debt | 4,547 | 4,549 | 6,284 | 6,285 | 6,287 | 6,289 | 7,290 | 7,292 |
| Cash flow | ||||||||
| Operating cash flow | 761 | 259 | 161 | 1,273 | 512 | 646 | 449 | 641 |
| Capital expenditure | -39 | -37 | -27 | -46 | -44 | -51 | -41 | -40 |
| Free cash flow | 722 | 222 | 134 | 1,226 | 468 | 594 | 408 | 600 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2022 at +15.4%, weakest 2024 at −40.9%. 3 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 28 Oct 2026 | −$0.14 |
| 29 Jul 2026 | $0.66 |
| 29 Apr 2026 | $2.15 |
| 6 Feb 2026 | −$0.35 |
| 30 Oct 2025 | $3.17 |
| 31 Jul 2025 | $4.33 |
| 1 May 2025 | $1.64 |
| 12 Feb 2025 | $1.83 |
| 30 Oct 2024 | $2.66 |
| 1 Aug 2024 | $4.00 |
| 24 Apr 2024 | $2.70 |
| 14 Feb 2024 | $1.71 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €33bn
- Market cap in trading currency
- $36.9bn
- Enterprise value
- $42.9bn
- P/E
- 107.6
- P/S
- 3.58
- P/B
- 1.95
- EV/Sales
- 4.16
- EV/EBITDA
- 33.2
- Earnings yield
- 0.9%
- FCF yield
- 5.6%
Results (last four quarters)
- Revenue
- $10.3bn
- Gross profit
- $7.62bn
- EBITDA
- $1.29bn
- Net income
- $348m
- Earnings per share
- $2.32
- Revenue per share
- $69.66
- Revenue growth
- +10.6%
- Earnings growth
- −104.4%
Profitability
- Gross margin
- 74.0%
- Operating margin
- 7.3%
- Net margin
- 3.4%
- Return on equity
- 1.9%
- Return on assets
- 1.1%
Balance sheet and cash flow
- Cash
- $1.30bn
- Cash per share
- $8.82
- Financial debt
- $7.29bn
- Debt/equity %
- 39
- Current ratio
- 1.95
- Book value per share
- $128.01
- Operating cash flow
- $2.25bn
- Free cash flow
- $2.07bn
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 148m
- Volume
- 1.13m
- Avg. volume 3 months
- 1.08m
- Relative volume
- 1.0
Price and technicals
- Price
- $249.59
- 1 day
- +1.0%
- 52-week high
- $254.87
- 52-week low
- $164.42
- Distance to 52-week high
- −2.1%
- Distance to 52-week low
- +51.8%
- Distance to 50-day line
- +5.4%
- Distance to 200-day line
- +20.6%
- RSI (14)
- 54
- Volatility 1M
- 28.7%
Performance
- 1 week
- −1.5%
- 1 month
- −1.7%
- 3 months
- +14.4%
- 6 months
- +28.8%
- YTD
- +41.8%
- 1 year
- +48.6%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has BIIB performed since 11/2016?
$10,000 grew to $7,841 by 20 Nov 2026, which is −2.4% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is BIIB?
Volatility was 31.0% per year, measured on monthly returns. The largest decline from a peak was −72.7%, with the low in 04/2025.
How does BIIB compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, BIIB returned −2.4% at 31.0%. The correlation of monthly returns was 0.13; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.